NASDAQ OMX Stockholm AB has admitted Serendex Pharmaceuticals A/S shares to trading on First North NOK, with effect from July 11, 2014.
The shares will be traded on the First North NOK segment.
|Clearing:||Central Counterparty (CCP) clearing through EuroCCP|
|Order book ID:||101906|
|Market Segment / no:||First North NOK/195|
|Tick Size / no:||Equities, NOK/208|
For further information concerning this exchange notice please contact Anna Jansson or Patrik Hellgren at telephone + 46 8 405 60 00.